Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

of Health (NIH). This compares to $893,002 of grant revenue reported for the same period in 2011. As of March 31, 2012, there is approximately $3.3 million in unused IPCAVD grant funds available for use through August 31, 2012 (the end of the original project period).

Research and development (R&D) expenses were $1,072,354 for the three months ended March 31, 2012, compared with $838,467 for the comparable period in 2011. R&D expenses include direct costs funded by the IPCAVD grant, as well as vaccine manufacturing costs and expenses related to the Phase 1/2 clinical trial, being sponsored by GeoVax, of the Company's therapeutic HIV vaccine. Costs associated with the Phase 2a clinical trial of GeoVax's preventative HIV vaccine, being conducted by the HVTN, are being funded directly by the NIH and are therefore not reflected in GeoVax's financial statements. General and administrative (G&A) expenses were $512,818 and $661,813 for the three months ended March 31, 2012 and 2011, respectively.

GeoVax reported cash balances of $2,240,486 at March 31, 2012, as compared to $1,167,980 at December 31, 2011. Summarized financial information is attached. Further information concerning the Company's financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

About GeoVax's TechnologyGeoVax's unique two component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV T cell and anti-HIV antibody immune responses. GeoVax's DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA. Both the DNA and MVA express the three major proteins of the AIDS virus: Gag, Pol, and Env, and produce non-infectious virus-like-particles. GeoVax's vaccines are unique in expressing virus-like particles that display the trimeric membrane bound form of the HIV-
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  MedSpring Urgent Care, an ... clinic at 517 S. Lamar Blvd., Austin, TX ... clinic is located on the southeast corner of Barton Springs ... from 9 a.m. - 9 p.m. daily, including weekends and holidays. ... Texas, Central Austin , Anderson Mill , ...
(Date:7/28/2014)...  TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or ... development, marketing and distribution of opioid-related immunotherapies, announced ... with the Securities and Exchange Commission in connection ... be held on Thursday, September 4, 2014, at ... for determining those shareholders eligible to receive notice ...
(Date:7/28/2014)... July 28, 2014 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution provider ... diagnostic imaging centers in China , ... of Directors declared a special cash dividend of US$0.30 ... ("ADS")) on the Company,s outstanding ordinary shares. The total ...
Breaking Medicine Technology:MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3Concord Medical Declares Special Dividend 2
... 2011 ViroPharma Incorporated (Nasdaq: VPHM ) today ... ViroPharma, will present at the Citi 2011 Global Healthcare Conference ... conference is being held at the Hilton New York Hotel ... and chief financial officer, of ViroPharma, will present at the ...
... Feb. 28, 2011 Rock Creek Pharmaceuticals, a wholly ... CIGX ) has been notified by the Roskamp Institute ... review board (IRB) approval to conduct a three-month, multi-site ...  The study (referred to as the "Flint Study"), will ...
Cached Medicine Technology:ViroPharma to Participate in Two March Healthcare Conferences 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 3Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 4
(Date:7/28/2014)... The Wireline Services Market in Europe report ... analysis and forecast of revenue. The Wireline services market in ... 2013 to $2.4 billion by 2019, at a CAGR of ... of the Wireline Services Market in Europe report, to get ... a glimpse of the segmentation in the European Wireline Services ...
(Date:7/28/2014)... 28, 2014 (HealthDay News) -- People with higher levels ... and diabetes, a new study suggests. Unlike white ... fat actually improves insulin sensitivity, blood sugar control and ... and obese people," Labros Sidossis, a professor of internal ... University of Texas Medical Branch at Galveston, said ...
(Date:7/28/2014)... July 28, 2014 In response to ... face today, BlogHer, The Center for American Progress and ... Life Work,” a campaign to raise awareness and promote ... the U.S. The joint initiative was announced on Saturday ... BlogHer; Judith Warner, Senior Fellow, The Center for American ...
(Date:7/28/2014)... Irresistible infants have met their match with a ... online gifting company specializes in homemade chicken noodle soup and creates ... package starts with home-from-the-hospital essentials every new parent will love:, ... rolls , 6 cookies , a ladle ... ready to heat and eat upon delivery, so parents can relax ...
(Date:7/28/2014)... 28, 2014 The Europe Carotenoids & ... antioxidants market in Europe with analysis and forecast of ... in 2012 to $765.93 million by 2018, at a ... through the TOC of the Europe Carotenoids & Antioxidants ... analysis provided. It also provides a glimpse of the ...
Breaking Medicine News(10 mins):Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Healthy 'Brown Fat' May Cut Odds for Obesity, Diabetes 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 4Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 5Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 4
... who practiced for nearly 30 years in a small medical ... of the American College of Physicians (ACP) testified today before ... half of our members who are involved in direct patient ... 20 percent of these physicians are in solo practices," the ...
... YORK, March 18 The International Trachoma Initiative (ITI) ... announced today that they will join forces to leverage ... Trachoma, a Neglected Tropical Disease (NTD) that is ... million people in 56 countries. While trachoma can be ...
... time to progress and cause real damage, doctors say , , ... Richardson may have suffered critical brain damage after a seemingly ... many people wondering how this could happen. , But experts ... as relatively benign as a concussion, to potentially lethal brain ...
... birth rate declined slightly in 2007 a finding that the ... a new trend in improved maternal and infant health. , ... gestation (late preterm) and among babies born to African American and ... birth rate, and hope that the emphasis we,ve put on the ...
... Educate Customers on AntibioticsLANDOVER, Md., March 18 ... free antibiotic program through July 11, 2009. The Company, ... District of Columbia, will continue to provide free of ... and their Giant BonusCard. The initial program launched on ...
... of family skiing in Canada ended with actress Natasha Richardson hospitalized with ... the exception and not the rule, the American Academy of Orthopaedic Surgeons ... on the slopes., , ... those frigid temperatures can produce on the ski slopes , ...
Cached Medicine News:Health News:Medicine's small business practices should be supported by federal budget 2Health News:International Trachoma Initiative and the Task Force for Child Survival and Development Announce New Merger to Eliminate Blinding Trachoma and Fight Against Other Neglected Tropical Diseases 2Health News:Brain Hemorrhage May Explain Natasha Richardson's Condition 2Health News:Brain Hemorrhage May Explain Natasha Richardson's Condition 3Health News:Giant Food Extends Its Free Antibiotic Prescription Program Through July 11, 2009 2Health News:Media Alert: Tips on Skiing Safely From the American Academy of Orthopaedic Surgeons 2
Anesthesia Associates Model 100 Compact Peripheral Nerve Stimulator, incorporates the latest state-of-the-art electronics with solid state cicuitry to ensure trouble-free operation and extended batte...
... Based on the original MS-III ... electrosurgery certification, enhanced keypad ... ,The MiniStim® MS-IV peripheral ... for neuromuscular monitoring in operating ...
... is a super-light polypropylene mesh which offers ... is reduced considerably. Optilene Mesh LP is ... hernia repair procedures. It perfectly conforms,to anatomical ... Mesh LP adapts to the movements of ...
... a mesh plug to treat large or ... hernias and femoralhernias. The self-expanding plug perfectly ... completely. Premilene Mesh Self-Forming Plug is a ... Mesh. The plug corresponds with all properties ...
Medicine Products: